Specific targeting of CD33(+) leukemia cells by a natural killer cell line modified with a chimeric receptor

Leuk Res. 2005 Mar;29(3):301-6. doi: 10.1016/j.leukres.2004.07.005.

Abstract

We directed the human natural killer (NK) cell line YT by gene transfer of a humanized chimeric immunoglobulin T cell receptor to CD33, a marker on myeloid leukemias. The chimeric receptor was generated using a CD33 specific single-chain Fv (scFv) fragment based on the humanized antibody HuM195, the human IgG1 Fc domains and the human CD3 zeta signal chain. YT cells transfected by electroporation with the chimeric receptor gene specifically lysed the acute myeloid leukemia (AML) cell line KG1. This gene-modified NK cell line available in unlimited source could be an attractive tool in immunotherapy.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antibodies, Monoclonal / genetics
  • Antibodies, Monoclonal / immunology
  • Antibodies, Monoclonal, Humanized
  • Antigens, CD / genetics
  • Antigens, CD / immunology
  • Antigens, Differentiation, Myelomonocytic / genetics
  • Antigens, Differentiation, Myelomonocytic / immunology
  • Cell Line
  • Cytotoxicity Tests, Immunologic
  • Electroporation
  • Flow Cytometry
  • Gene Transfer Techniques*
  • Humans
  • Immunoglobulin Fc Fragments / genetics
  • Immunoglobulin Fc Fragments / immunology
  • Immunoglobulin G / genetics
  • Immunoglobulin G / immunology
  • Killer Cells, Natural / immunology*
  • Leukemia / drug therapy*
  • Receptors, Immunologic / genetics
  • Receptors, Immunologic / immunology*
  • Recombinant Fusion Proteins
  • Sialic Acid Binding Ig-like Lectin 3
  • Transfection

Substances

  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Humanized
  • Antigens, CD
  • Antigens, Differentiation, Myelomonocytic
  • CD33 protein, human
  • Immunoglobulin Fc Fragments
  • Immunoglobulin G
  • Receptors, Immunologic
  • Recombinant Fusion Proteins
  • Sialic Acid Binding Ig-like Lectin 3
  • lintuzumab